Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yasuhiro Nakashima, MD, PhD"'
Autor:
Yasuyuki Kurihara, MD, Takayuki Honda, MD, PhD, Akira Takemoto, MD, PhD, Katsutoshi Seto, MD, PhD, Satoshi Endo, MD, Kousuke Tanimoto, MD, PhD, Susumu Kirimura, MD, PhD, Masashi Kobayashi, MD, PhD, Shunichi Baba, MD, PhD, Yasuhiro Nakashima, MD, PhD, Ryo Wakejima, MD, PhD, Rie Sakakibara, MD, PhD, Hironori Ishibashi, MD, PhD, Johji Inazawa, MD, PhD, Toshihiro Tanaka, MD, PhD, Yasunari Miyazaki, MD, PhD, Kenichi Okubo, MD, PhD
Publikováno v:
JTCVS Open, Vol 20, Iss , Pp 183-193 (2024)
Introduction: TP53 is a strong tumor suppressor gene; its deactivation contributes to carcinogenesis and influences clinical outcomes. However, the prognostic influence of p53 deactivation on early relapse in patients with surgically resected non–s
Externí odkaz:
https://doaj.org/article/4102ee1106d24518a153130f60139603
Autor:
Yuya Ide, MD, Takahiro Horie, MD, PhD, Naritatsu Saito, MD, PhD, Shin Watanabe, MD, PhD, Chiharu Otani, MD, Yui Miyasaka, BSc, Yasuhide Kuwabara, MD, PhD, Tomohiro Nishino, MD, PhD, Tetsushi Nakao, MD, PhD, Masataka Nishiga, MD, PhD, Hitoo Nishi, MD, PhD, Yasuhiro Nakashima, MD, PhD, Fumiko Nakazeki, MD, PhD, Satoshi Koyama, MD, PhD, Masahiro Kimura, MD, Shuhei Tsuji, MD, Randolph Ruiz Rodriguez, MD, Sijia Xu, MD, Tomohiro Yamasaki, MD, Toshimitsu Watanabe, MD, Masamichi Yamamoto, PhD, Motoko Yanagita, MD, PhD, Takeshi Kimura, MD, PhD, Akira Kakizuka, MD, PhD, Koh Ono, MD, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 4, Iss 6, Pp 701-714 (2019)
Summary: No effective treatment is yet available to reduce infarct size and improve clinical outcomes after acute myocardial infarction by enhancing early reperfusion therapy using primary percutaneous coronary intervention. The study showed that Kyo
Externí odkaz:
https://doaj.org/article/d66cbcb274f6484fb40460d224a0132a